Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E P, Faison"'
Publikováno v:
Archives of internal medicine. 155(4)
Losartan potassium, the first nonpeptide selective blocker of angiotensin II at the AT1 receptor, has been shown to exhibit clinical antihypertensive effects. The aim of the present study was to characterize the efficacy and duration of action of los
Autor:
Y, Lacourcière, H, Brunner, R, Irwin, B E, Karlberg, L E, Ramsay, D B, Snavely, T W, Dobbins, E P, Faison, E B, Nelson
Publikováno v:
Journal of hypertension. 12(12)
To compare the incidence of cough in patients with a history of angiotensin converting enzyme (ACE) inhibitor-related cough who received losartan [a type 1 angiotensin II (Ang II) receptor antagonist], lisinopril (an ACE inhibitor) or hydrochlorothia
Publikováno v:
Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 12(2)
A common adverse experience in hypertensive patients treated with angiotensin converting enzyme (ACE) inhibitors is a tickling dry cough.The aim of the present study was to review clinical observations and mechanisms of cough associated with ACE inhi
Publikováno v:
Clinical pharmacology and therapeutics. 55(3)
Two hundred eighty-six patients with mild to moderate hypertension who had untreated diastolic blood pressure while seated of 95 to 115 mm Hg were randomized to receive placebo or once-daily doses of 2.5, 5, or 10 mg of the dihydropyridine calcium ch
Publikováno v:
Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 2(3)
Synthetic atrial natriuretic factor (ANF) relaxed agonist-induced tone in rabbit aortic rings as well as intrinsic, myogenic contractions in the isolated rabbit facial vein (IC50s = 0.1 to 5 nM). Tissues depolarized by high levels of K+ were refracto
Autor:
R. J. Winquist, Patricia K. Lumma, David E. McClure, David A. Claremon, S. A. Rosenthal, Gregory J. Kaczorowski, E. P. Faison, John J. Baldwin, Graham M. Smith, M. J. Trumble
Publikováno v:
ChemInform. 18
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 224(1)
Using the isolated rat vas deferens, we have confirmed the existence of P1 purinergic receptors whose activation results in an inhibition of the neurogenic twitch of the vas deferens. The observed order of potency for agonists (adenosine ethyl carbox